Renaissance Technologies’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Renaissance Technologies’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-467	Closed	-$155K	–	3913
2021 Q3	$155K	Buy	+467	New	+$184K	﹤0.01%	3254
2021 Q1	–	Sell	-594	Closed	-$212K	–	3334
2020 Q4	$212K	Buy	594 +529	+814%	+$193K	﹤0.01%	3114
2020 Q3	$23K	Buy	+65	New	+$27.1K	﹤0.01%	3317
2020 Q1	–	Sell	-162	Closed	-$107K	–	3457
2019 Q4	$107K	Buy	+162	New	+$87K	﹤0.01%	3306
2015 Q2	–	Sell	-28	Closed	-$190K	–	3230
2015 Q1	$190K	Buy	+28	New	+$337K	﹤0.01%	2893

Other funds holding CANF

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAN

Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Renaissance Technologies's CANF Position: Q4 2021 in Review

Renaissance Technologies sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q4 2021, closing a stake of 467 shares — an estimated $155K sold.

Renaissance Technologies first reported a position in CANF in Q1 2015 and held it in 5 quarters. The position peaked at $212K in Q4 2020. 15 funds tracked by Wall St. Rank hold CANF as of Q4 2021.

Renaissance Technologies reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Renaissance Technologies sold 467 Can-Fite BioPharma American Depositary Shares shares in Q4 2021, an estimated $155K.
Renaissance Technologies first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2015 and held it in 5 quarters.
Renaissance Technologies's Can-Fite BioPharma American Depositary Shares position peaked at $212K in Q4 2020.
15 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q4 2021.

Based on Renaissance Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.